Alpha Tau Medical price target cut to $20.6 across 5 analysts
According to estimates from 5 analysts, the average price target for Alpha Tau Medical Ltd. shares fell from $21.5 to $20.6, with forecasts ranging from $16 to $30 per share. Using the November 19, 2026 closing price as a reference, the new target implies a potential upside of about 82%. The consensus rating from the 5 analysts remains "buy": 5 buy, 0 hold and 0 sell.
In 30 seconds
- Alpha Tau Medical's average price target falls from $21.5 to $20.6, according to 5 analysts
- Forecast range runs from $16 to $30 per share
- The new target implies a potential upside of 82% versus the November 19, 2026 close
IASummary generated by artificial intelligence from a story by TradingView. It may contain errors: the original source prevails.




Comments
Be respectful. Comments reported by several people are hidden until a moderator reviews them.
You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.